These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 16393442

  • 1. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss.
    Dinges DF, Arora S, Darwish M, Niebler GE.
    Curr Med Res Opin; 2006 Jan; 22(1):159-67. PubMed ID: 16393442
    [Abstract] [Full Text] [Related]

  • 2. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 3. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T.
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T.
    Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
    [Abstract] [Full Text] [Related]

  • 5. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
    Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ.
    Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356
    [Abstract] [Full Text] [Related]

  • 6. Maintenance of wakefulness with lisdexamfetamine dimesylate, compared with placebo and armodafinil in healthy adult males undergoing acute sleep loss.
    Gasior M, Freeman J, Zammit G, Donnelly P, Gao J, Ferreira-Cornwell MC, Roth T.
    J Clin Psychopharmacol; 2014 Dec; 34(6):690-6. PubMed ID: 25159886
    [Abstract] [Full Text] [Related]

  • 7. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):552-9. PubMed ID: 18053628
    [Abstract] [Full Text] [Related]

  • 8. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
    Killgore WD, Rupp TL, Grugle NL, Reichardt RM, Lipizzi EL, Balkin TJ.
    J Sleep Res; 2008 Sep 15; 17(3):309-21. PubMed ID: 18522689
    [Abstract] [Full Text] [Related]

  • 9. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.
    Wesensten NJ, Killgore WD, Balkin TJ.
    J Sleep Res; 2005 Sep 15; 14(3):255-66. PubMed ID: 16120100
    [Abstract] [Full Text] [Related]

  • 10. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat.
    Wisor JP, Dement WC, Aimone L, Williams M, Bozyczko-Coyne D.
    Pharmacol Biochem Behav; 2006 Nov 15; 85(3):492-9. PubMed ID: 17134745
    [Abstract] [Full Text] [Related]

  • 11. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships.
    Darwish M, Bond M, Ezzet F.
    J Clin Pharmacol; 2012 Sep 15; 52(9):1328-42. PubMed ID: 22039290
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD, Harsh JR, Yang R, Rippon GA, Lankford DA.
    J Clin Psychiatry; 2010 Jan 15; 71(1):32-40. PubMed ID: 20051221
    [Abstract] [Full Text] [Related]

  • 13. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T, Rippon GA, Arora S.
    Sleep Breath; 2008 Mar 15; 12(1):53-62. PubMed ID: 17874255
    [Abstract] [Full Text] [Related]

  • 14. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.
    Darwish M, Kirby M, Hellriegel ET, Yang R, Robertson P.
    Drugs Aging; 2011 Feb 01; 28(2):139-50. PubMed ID: 21275439
    [Abstract] [Full Text] [Related]

  • 15. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D, Chevret S, Quera-Salva MA, Laforêt P, Lofaso F, Verschueren A, Pouget J, Eymard B, Annane D.
    Clin Ther; 2009 Aug 01; 31(8):1765-73. PubMed ID: 19808135
    [Abstract] [Full Text] [Related]

  • 16. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.
    Sleep; 2002 Dec 01; 25(8):905-9. PubMed ID: 12489899
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan 01; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

  • 18. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
    Saletu M, Anderer P, Saletu-Zyhlarz GM, Mandl M, Saletu B, Zeitlhofer J.
    Sleep Med; 2009 Sep 01; 10(8):850-8. PubMed ID: 19342295
    [Abstract] [Full Text] [Related]

  • 19. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ, Liu K, Hutzelmann J, Snavely D, Snyder E, Ceesay P, Lines C, Michelson D, Roth T.
    Sleep Med; 2013 Oct 01; 14(10):955-63. PubMed ID: 23920422
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.